Article info
PDFPostScript
Letter to the editor
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin home therapy in a patient with primary immunodeficiency
- Correspondence to Emma Knight, University Hospital of Wales, Department of Medical Biochemistry and Immunology, Heath Park, Cardiff CF14 4XW, Wales, UK; emma.knight{at}cardiffandvale.wales.nhs.uk
Citation
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin home therapy in a patient with primary immunodeficiency
Publication history
- Accepted May 17, 2010
- First published July 29, 2010.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.